During the 22nd European Society of Retina Specialists Congress in Hamburg, Germany., investigators noted that Yusar and colleagues from the Vitreoretinal Services, Centre for Sight, Delhi, India.
Taiwanese researchers reported that patients with retinitis pigmentosa (RP) have a significantly greater risk of developing primary angle-closure glaucoma (PACG) than those without RP.
Man Chen Hung, MD, and Yu Yen Chen, MD, from Taichung Veterans General Hospital, Taichung-City, Taiwan, conducted a population-based, retrospective cohort study using the National Health Insurance Research Database to identify patients between January 1, 2001, to December 31, 2011.
The research was presented at the 22nd annual Euretina Congress.
RP and PACG are genetic diseases with similar genetic variants and pathophysiology between them. The investigators explained that elevated angle-closure related intraocular pressure (IOP) may aggregate the visual impairment in patients with RP, they wanted to determine if patients with RP have a significantly higher risk of PACG development. This knowledge may facilitate for early intervention in these patients.
More than 6000 patients with RP were identified; almost 25,000 patients served as controls for comparison. RP and comparison groups were matched on age and sex.
The mean age of the cohort was 49.0 ± 18.1 years. During the study period, the cumulative incidence of PACG in the RP group was significantly higher than in the comparison group (1.61% vs. 0.81%, p < 0.0001). univariate Cox regression analysis showed that RP, age, female sex, hypertension, diabetes mellitus, hyperlipidemia, cataract, and lens subluxation all showed a significantly higher risk of PACG.
After adjusting for age, sex, comorbidities, cataract, and lens subluxation, Hung and Chen found that RP still significantly increased the hazard of developing PACG (hazard ratio, 2.04; 95% confidence interval, 1.60–2.59, p < 0.0001).
Based on their findings, the researchers concluded that “the nationwide population-based cohort study showed that people with RP are at a significantly greater risk of developing PACG than individuals without RP.”